NeuroBo Pharmaceuticals, Inc. (NRBO)
NASDAQ: NRBO · IEX Real-Time Price · USD
+0.095 (2.19%)
At close: Jul 23, 2024, 2:41 PM
-0.225 (-5.08%)
After-hours: Jul 23, 2024, 6:00 PM EDT

NeuroBo Pharmaceuticals Statistics

Total Valuation

NRBO has a market cap or net worth of $24.38 million. The enterprise value is $9.60 million.

Market Cap 24.38M
Enterprise Value 9.60M

Important Dates

The next estimated earnings date is Wednesday, August 7, 2024, after market close.

Earnings Date Aug 7, 2024
Ex-Dividend Date n/a

Share Statistics

NRBO has 5.67 million shares outstanding. The number of shares has increased by 0.60% in one year.

Shares Outstanding 5.67M
Shares Change (YoY) +0.60%
Shares Change (QoQ) -0.02%
Owned by Insiders (%) 67.86%
Owned by Institutions (%) 9.59%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 2.52
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.46, with a Debt / Equity ratio of 0.02.

Current Ratio 2.46
Quick Ratio n/a
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -90.20% and return on invested capital (ROIC) is -197.28%.

Return on Equity (ROE) -90.20%
Return on Assets (ROA) -69.50%
Return on Capital (ROIC) -197.28%
Revenue Per Employee n/a
Profits Per Employee -$2.07M
Employee Count 8
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -9.58% in the last 52 weeks. The beta is -0.29, so NRBO's price volatility has been lower than the market average.

Beta (5Y) -0.29
52-Week Price Change -9.58%
50-Day Moving Average 4.30
200-Day Moving Average 4.03
Relative Strength Index (RSI) 45.79
Average Volume (20 Days) 106,776

Short Selling Information

The latest short interest is 92,600, so 1.63% of the outstanding shares have been sold short.

Short Interest 92,600
Short Previous Month 58,538
Short % of Shares Out 1.63%
Short % of Float n/a
Short Ratio (days to cover) 1.20

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -20.25M
Pretax Income -16.58M
Net Income -16.58M
EBITDA -16.57M
EBIT -16.58M
Earnings Per Share (EPS) -$3.22
Full Income Statement

Balance Sheet

The company has $15.99 million in cash and $187,000 in debt, giving a net cash position of $15.80 million or $2.79 per share.

Cash & Cash Equivalents 15.99M
Total Debt 187,000
Net Cash 15.80M
Net Cash Per Share $2.79
Equity (Book Value) 10.08M
Book Value Per Share 1.78
Working Capital 9.94M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.69 million and capital expenditures -$51,000, giving a free cash flow of -$14.75 million.

Operating Cash Flow -14.69M
Capital Expenditures -51,000
Free Cash Flow -14.75M
FCF Per Share -$2.90
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NRBO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.60%
Shareholder Yield -0.60%
Earnings Yield -65.26%
FCF Yield -58.04%

Analyst Forecast

The average price target for NRBO is $10.00, which is 125.99% higher than the current price. The consensus rating is "Strong Buy".

Price Target $10.00
Price Target Difference 125.99%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on December 21, 2023. It was a reverse split with a ratio of 1:8.

Last Split Date Dec 21, 2023
Split Type Reverse
Split Ratio 1:8


Altman Z-Score n/a
Piotroski F-Score 1